RA Capital Management »

Adicet Bio shares owned by RA Capital Management

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 7.5M 2.35
2022-09-30 $29M 2.1M 14.22

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Legend Biotech Corp- SH (LEGN)
Janux Therapeutics SH (JANX)
Aerovate Therapeutics SH (AVTE)
Rhythm Pharmaceuticals SH (RYTM)
Evolent Health Inc - A SH (EVH)
Newamsterdam Pharma Co Nv SH (NAMS)
Rxsight SH (RXST)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
4d Molecular Therapeutics In SH (FDMT)
Biogen SH (BIIB)
Pepgen SH (PEPG)
Geron Corp SH (GERN)

View all positions for RA Capital Management

Top funds holding Adicet Bio

OrbiMed Advisors
RA Capital Management
Tang Capital Management
Balyasny Asset Management
Rtw Investments
Millennium Management
Morgan Stanley
Goldman Sachs Group
BlackRock
Vanguard Group
Carlyle
Commodore Capital
Blackstone Group
Geode Capital Management
Schonfeld Strategic Advisors

View all funds holding Adicet Bio